Lupin's partnership program is designed to foster collaborations with companies looking to extend their product lifecycles
Max and Luna personify HRV Pharma’s core values of trust, loyalty, and authentic partnership
Pioneering innovation aims to transform anticoagulant therapy and improve patient outcomes
Sanofi Ventures drives innovation through leading and participating in private financing rounds for pioneering healthcare companies
Bayer Co.Lab AdVenture platform will accelerate biotech innovation through global investment networks
This marks the first of four new U.S. manufacturing sites that Lilly plans to announce this year
Program provides access to Lilly-trained artificial intelligence to help accelerate breakthrough medicines
Funding to support Phase 2b trial with MRM Health’s lead program MH002 in ulcerative colitis and advance two additional programs to IND approval
Teva received Fast Track designation from the U.S. Food and Drug Administration for emrusolmin (TEV-56286), an investigational treatment for Multiple System Atrophy (MSA) in Phase 2 development
Subscribe To Our Newsletter & Stay Updated
